Compliance
Documentation your safety and legal partners can follow
DOT drug and alcohol testing (regulated)
DOT (Department of Transportation) drug and alcohol testing is governed by federal rules—not only by your employee handbook. In practice that means collectors, labs, and paperwork must line up with what Part 40 and your operating administration require for safety-sensitive employees.
What federal rules decide for you
Core framework: 49 CFR Part 40 plus the modal regulations for your industry (for example, FMCSA for many motor carriers). Under those rules, employers do not freely pick “any” specimen or lab—the regulations shape allowed specimen types, collection steps, alcohol testing methods (breath or saliva where authorized), medical review, and how results are reported for covered roles.
- Specimens and procedures — urine, oral fluid (when authorized for your mode and date range), breath alcohol where applicable—each with defined collection and custody steps.
- Laboratories — DOT drug specimens go to labs certified under the HHS Mandatory Guidelines (the SAMHSA laboratory certification program employers and TPAs use to qualify lab accounts).
- Why it feels different from office policy — random testing often flows through a consortium or TPA; post-accident and reasonable-suspicion events bring timing and documentation pressure that typical HR workflows do not always match.
Roles on the employer side
- DER — your designated employer representative is the usual contact for test authority and program questions as collections move.
- Consortium / TPA — often runs random selections, lab routing, and MIS-style reporting expectations your mode requires.
- Collectors — must follow the correct federal custody steps so results hold up in a regulated program—not improvise from habit or non-DOT practice.
What we do in the field
We train collectors on applicable DOT collection procedures and work with your DER when on-site questions come up—so the visit matches the order, the right forms are used, and specimens are sealed and routed the way your administrator expects.
Direct observation collections
In an observed urine collection, a same-gender observer watches the donor provide the specimen per the rules that apply to your program. For many DOT urine drug tests, Part 40 specifies when direct observation is required—not for every collection. Employers encounter it most often in compliance-driven situations such as return-to-duty and follow-up testing after a DOT violation, and in other circumstances the regulations describe (for example, certain elevated temperature or tampering scenarios). Your DER and compliance advisors confirm when observation applies to a given event; we execute the collection and custody steps once the order is clear.
Non-DOT programs use observation only when your policy and state law authorize it. Whether the test is DOT or handbook-led, staging still needs a private restroom or collection area that meets procedure—not a shortcut around donor dignity or documentation.
For modality detail on regulated urine workflows, see DOT drug testing.
Non-DOT workplace testing (policy-led)
Non-DOT programs are driven by your written policy, candidate and employee notice, and state workplace drug-testing law—which varies by state for hiring, random, reasonable suspicion, post-accident, and other testing reasons. Employers often have more flexibility to choose matrices (such as urine, oral fluid, hair, or breath alcohol for alcohol) when law and policy allow, but that flexibility still has to match what your documents actually say and what your third-party administrator or lab accepts.
Observation, donor rights, disciplinary steps, and alternate specimens when someone cannot provide a sample are usually defined in your handbook or program rules—not by Part 40. Practical issues (who can authorize a test, how supervisors document suspicion, how fast you need a collector after an incident) still need clear answers before collection day so the field team is not improvising.
We align specimen types, panels, observation expectations, and paperwork with the policy and orders you provide, and we surface mismatches early—for example, when a site requests a matrix the policy does not authorize or when DOT-covered employees need to be routed to a federal-compliant test instead of a general workplace screen.
Why the split matters on collection day
The same employer can run both DOT and non-DOT programs—for instance, regulated drivers under Part 40 alongside office staff under a handbook-only policy. The wrong form, wrong specimen, or wrong alcohol modality can undermine an entire test for the regulated side while still being “fine” for a purely internal policy screen. Clear intake (who is being tested, under which program, and on what order) keeps collections aligned with how you will defend the result later.
For a deeper plain-language comparison, see our DOT vs non-DOT drug testing guide and discuss specifics with your DER, HR, and compliance partners when you scope work with us.
Observed collections — common questions
- When is a direct observation collection required?
- Under DOT rules, it depends on the test reason and the situation—not every urine collection is observed. Return-to-duty and follow-up drug tests are common examples where Part 40 calls for direct observation; other triggers are defined in the regulations. For non-DOT tests, your policy and applicable state law govern. Your DER, TPA, or counsel—not the collection site—should confirm whether a specific order must be observed before collection day.
- Do you support return-to-duty and follow-up observed collections?
- Yes, when your order states a DOT return-to-duty or follow-up (or other authorized) test and observation is required for that event, we coordinate qualified collectors and same-gender observation per applicable procedures. Share test reason, program type, and site constraints during intake so dispatch matches the order.
- Can you coordinate observed collections for DOT programs?
- Yes. We execute DOT-appropriate urine collections—including observed collections when the order and regulations require them—using the paperwork and steps your mode and TPA expect. If the requisition is ambiguous, we stop and escalate rather than guess.
Discuss your regulatory context
Tell us whether you are FMCSA, multi-mode DOT, or non-DOT only. We will confirm collection feasibility against your stated program.